Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation

被引:11
作者
Hino, Akihisa [1 ]
Fukushima, Kentaro [1 ,8 ]
Kusakabe, Shinsuke [1 ]
Ueda, Tomoaki [1 ]
Sudo, Takao [1 ,2 ]
Fujita, Jiro [1 ]
Motooka, Daisuke [2 ,3 ]
Takeda, Aya K. K. [4 ]
Shinozaki, Natsuko O. O. [4 ]
Watanabe, Satoshi [4 ]
Yokota, Takafumi [1 ,5 ]
Shibayama, Hirohiko [1 ,6 ]
Nakamura, Shota [2 ,3 ,9 ]
Hosen, Naoki [1 ,2 ,7 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Japan
[2] Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Suita, Japan
[3] Osaka Univ, Res Inst Microbial Dis, Dept Infect Metagen, Suita, Japan
[4] Cykinso Inc, Tokyo, Japan
[5] Osaka Int Canc Inst, Dept Hematol, Osaka, Japan
[6] Natl Hosp Org, Osaka Natl Hosp, Dept Hematol, Osaka, Japan
[7] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Lab Cellular Immunotherapy, Suita, Japan
[8] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan
[9] Osaka Univ, Res Inst Microbial Dis, Dept Infect Metagen, Suita, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
aGVHD; allogeneic haematopoietic stem cell transplantation; cGVHD; gut microbiota; second cancer; VERSUS-HOST-DISEASE; CHRONIC GRAFT; SOLID CANCERS; DIVERSITY; BUTYRATE; RISK;
D O I
10.1111/bjh.18574
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dysbiosis of the gut microbiota has been reported to increase early complications after allogeneic haematopoietic stem cell transplantation (allo-HSCT). However, it remains unclear whether gut microbial alterations persist during late complications, such as chronic graft-versus-host disease (cGVHD) or secondary cancers. Here, we analysed the gut microbiota of 59 patients who survived for 1-21.7 years (median, 6.4 years) after allo-HSCT. Long-term survivors showed lower gut microbial diversity than the age- and sex-matched healthy controls. This decreased diversity was reflected in the reduced abundance of the butyrate-producing bacteria. Patients with a history of grade 3 acute graft-versus-host disease (aGVHD) exhibited higher Veillonella abundance than patients with a history of grade 1-2 or non-aGVHD cases. The abundance of Faecalibacterium showed no decrease only in limited cGVHD cases. Additionally, the microbial structure in the secondary cancer group was significantly different (p < 0.05) from that in the non-secondary cancer group. This study is the first to show that microbial dysbiosis is present over a 10-year lifetime after discharge following allo-HSCT. Our results suggest that these prolonged gut microbial alterations may be associated with the development and exacerbation of late complications in post-transplant survivors.
引用
收藏
页码:725 / 737
页数:13
相关论文
共 50 条
[31]   Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible [J].
Colunga-Pedraza, Perla R. ;
Gomez-De Leon, Andres ;
Saul Rodriguez-Roque, Carlos ;
Morcos-Sandino, Michelle ;
Colunga-Pedraza, Julia E. ;
Graciela Cantu-Rodriguez, Olga ;
Homero Gutierrez-Aguirre, Cesar ;
Gomez-Almaguer, David .
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03) :259.e1-259.e6
[32]   Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant [J].
Zhao, Chenchen ;
Bartock, Matthew ;
Jia, Bei ;
Shah, Neal ;
Claxton, David F. ;
Wirk, Baldeep ;
Rakszawski, Kevin L. ;
Nickolich, Myles S. ;
Naik, Seema G. ;
Rybka, Witold B. ;
Ehmann, W. Christopher C. ;
Hohl, Raymond J. ;
Valentin, Jessica ;
Bernas-Peterson, Michelle ;
Gerber, Emily M. ;
Zimmerman, Michele ;
Mierski, Joseph A. ;
Mineishi, Shin ;
Zheng, Hong .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
[33]   Assessment of pre-and post-transplant concentrations of citrulline, zonulin, and calprotectin in children undergoing allogeneic hematopoietic cell transplantation [J].
Rohani, Pejman ;
Tejareh, Faezeh ;
Hamidieh, Amir Ali ;
Behfar, Maryam ;
Sohouli, Mohammad Hassan .
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2025, 73 (04)
[34]   Immune recovery and the risk of CMV/EB reactivation in children post allogeneic haematopoietic stem cell transplantation [J].
Janeczko, Malgorzata ;
Mielcarek, Monika ;
Rybka, Blanka ;
Ryczan-Krawczyk, Renata ;
Noworolska-Sauren, Dorota ;
Kalwak, Krzysztof .
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 41 (03) :287-296
[35]   Gut microbiota alteration during allogeneic haematopoietic cell transplantation: what can we do? [J].
Malard, Florent ;
Mohty, Mohamad .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (03) :351-353
[36]   Prioritising gynaecological care in post-haematopoietic stem cell transplant patients [J].
Jain, Arpita ;
Pandurangi, Monna ;
Jayaraman, Dhaarani ;
Vembu, Radha .
BMJ CASE REPORTS, 2025, 18 (01)
[37]   Rehabilitation after Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge [J].
Bertz, Hartmut .
CANCERS, 2021, 13 (24)
[38]   The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation [J].
Dybko, Jaroslaw ;
Sobczyk-Kruszelnicka, Malgorzata ;
Makuch, Sebastian ;
Agrawal, Siddarth ;
Dudek, Krzysztof ;
Giebel, Sebatian ;
Gil, Lidia .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
[39]   Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis [J].
Lissandre, S. ;
Bay, J-O ;
Cahn, J-Y ;
Porcher, R. ;
Cacheux, V. ;
Cabrespine, A. ;
Cornillon, J. ;
Cassinat, B. ;
de Latour, R. Peffault ;
Socie, G. ;
Robin, M. .
BONE MARROW TRANSPLANTATION, 2011, 46 (04) :557-561
[40]   Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation [J].
Bergeron, Anne ;
Chevret, Sylvie ;
de Latour, Regis Peffault ;
Chagnon, Karine ;
de Margerie-Mellon, Constance ;
Riviere, Frederic ;
Robin, Marie ;
Mani, Jean ;
Lorillon, Gwenael ;
Socie, Gerard ;
Tazi, Abdellatif .
EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (05)